Program areas at HSS
Patient care: Hospital for Special Surgery is committed to providing world-class care to its patients and helping them to regain their mobility, while also advancing research initiatives to explore and improve treatments for orthopedic and rheumatologic conditions. Hospital for Special Surgery operated 166 staffed beds as of december 31, 2022 and december 31, 2021; and 40 operating rooms as of december 31, 2022 and december 31, 2021. We performed 29,025 surgeries, a increase of 1,430 over the prior year, while non-surgical outpatient visits numbered 598,281, 50,809 more than 2021. Hospital for Special Surgery provided inpatient care to 11,876 patients, 658 less than 2021. of those in 2022, 11,625 were surgical. Total ambulatory surgical cases numbered 17,400, an increase of 2,087 from 2021. the Hospital has a diverse patient population serving those with public insurance (medicare and medicaid), private insurance (various payors) and the uninsured. the Hospital maintains a financial assistance program to assist those that cannot pay for its services and provides numerous other community benefit programs. Hospital for Special Surgery is also recognized as a magnet Hospital for excellence in nursing care. the Hospital is recognized for its excellence in patient care and is consistently ranked by u.s. news and world report in its specialties.
Education Institute: HSS education institute continued to make strides towards the mission to be "the most trusted educator" in the field of musculoskeletal health for patients, physicians, allied health professionals and the general public. In 2022 we strengthened strategic partnerships with our 22 education and academic advisory committees and councils, as well as furthering external community relations globally, engaging 36 partner countries. The HSS Orthopedic Residency program, voted #1 training program by board certified orthopaedists, trained 47 residents, 73 fellows, and 102 medical students in 2022. For other trainees, there were 545 in-rotators and 21 consults. In 2022, we engaged 6.4 million people through 6,500 cutting edge live and digital education programs, including our HSS e-academy, ACGME Programs, CME Accredited Activities, Simulation Learning & Training Center sessions, Global Partnership Initiatives, Kim Barrett Memorial Medical Library Users, and Community Education & Outreach Programs. EI also hosted 211 academic visitors and credentialed nearly 1,395 physicians and health care providers. We continue to set the highest standard with our ACCME accredited and non-accredited professional education programs. In 2022, the Education Institute through its continuing education and global academic partnerships departments, including HSS e-academy, delivered nearly 1,800 educational activities including onsite courses, grand rounds, internet live courses, internet enduring material and journal-based continuing medical education activities resulting in over 175,000 learner interactions with a diversity of healthcare professionals and teams. EI's Community Education & Outreach department reached 5.98 million consumers through more than 1,000 community education programs and videos.
RESEARCH: THE RESEARCH DIVISION OF HOSPITAL FOR SPECIAL SURGERY CONTINUED ITS ACTIVITIES IN 2022 TOWARD ENHANCING AND EXPANDING OUR RESEARCH IN MUSCULOSKELETAL DISEASES. RESEARCH AT HOSPITAL FOR SPECIAL SURGERY WORKS TO ADVANCE THE UNDERSTANDING AND TREATMENT OF MUSCULOSKELETAL DISORDERS THROUGH BASIC, TRANSLATIONAL AND CLINICAL RESEARCH AND EDUCATION. THE GOALS ARE TO IDENTIFY GENETIC, ENVIRONMENTAL, CELLULAR, STRUCTURAL AND MOLECULAR MECHANISMS UNDERLYING DISORDERS IMPORTANT IN ORTHOPEDICS, RHEUMATOLOGY AND RELATED DISCIPLINES AND TO DISCOVER EFFECTIVE APPROACHES FOR DIAGNOSIS PREVENTION, AND TREATMENT OF THESE DISORDERS. HSS Research Institute (HSSRI) is home to a uniquely collaborative culture in which basic scientists work together with clinician-investigators to accelerate discoveries that will result in new treatments and improved outcomes for musculoskeletal patients. HSS Research Institute is composed of basic, clinical, and translational scientists to accelerate discoveries that will result in new treatments and improved outcomes for musculoskeletal patients. The key programmatic areas that have allowed us to make major contributions to musculoskeletal health include (1) Bone Health and Implant Integration (2) Inflammation & Arthritis (3) Autoimmune Rheumatic Diseases (4) Joint Preservation and Regeneration, and a new program in (5) Musculoskeletal Pain. These programs are supported by an enabling infrastructure including a Genomics Center, Precision Medicine Laboratory, and Experimental Pathology. HSSRI has active collaborations with the Biomechanics Department, many clinical Departments including Orthopedic Services, Rheumatology/Medicine, and Imaging (Radiology), and is expanding collaborations with Physiatry, Anesthesia and Neurology. Combining HSSRI expertise with the volume, breadth, and depth of patients seen at HSS to develop unparalleled clinical research and populations health outcomes programs, can further the national and international visibility of our institution. AS A RESULT OF STRONG INTRA - AND INTER - PROGRAMMATIC INTERACTIONS, AND THE USE OF SHARED CORE RESOURCES, OUR PORTFOLIO OF INNOVATIVE DISCOVERY AND DEVELOPMENT HAS EXPANDED EXPONENTIALLY. TO PROVIDE THE FINAL COMPONENT NEEDED TO ACHIEVE BENCH-TO BEDSIDE RESEARCH, THE RESEARCH INSTITUTE, IN COLLABORATION WITH CLINICIAN RESEARCHERS HAS CREATED A DISTINGUISHED CLINICAL RESEARCH PROGRAM. In 2022, THE RESEARCH INSTITUTE was FUNDED BY AN OPERATING BUDGET OF $54 MILLION, SUPPORTED IN PART BY APPROXIMATELY $41 MILLION IN EXTRAMURAL FUNDS, INCLUDING $ 15 MILLION FROM NEWLY AWARDED FEDERAL GRANTS. THIS RESEARCH RESULTED IN over 1153 PUBLICATIONS among the 220 researchers IN 2022. HIGHLIGHTS FOR 2022 INCLUDE: continued advancement of HSS's research mission by: 1) supporting and retaining our most productive faculty, 2) mentoring the next generation of scientists, 3) expanding our collaborative efforts with clinicians and recruitment of full time clinical research scientists, and 4) supporting the infrastructure necessary to advance our research and ensure compliance, AND 5) SCIENTIFIC HIGHLIGHTS INCLUDE, laboratory studies in areas such as bone and implant integration, spine disc development, periprosthetic joint infection, tendon and ligament repair, biologics and autoimmune diseases (i.e. Rheumatoid Arthritis, Systemic Sclerosis, Lupus), REGENERATIVE MEDICINE; and SINGLE CELL SEQUENCING.